Abstract. Neutrophil gelatinase-associated lipocalin (NGAL), one of the most promising next-generation biomarkers in clinical nephrology, has received extensive attention. However, the basic role of its receptor (NGALR) remains unclear. Here, we have assessed the expression pattern of NGALR in injured glomeruli and explored the possible mechanism of the NGALR involvement in inflammation in human mesangial cells (HMc). The expression pattern of NGALR was detected by immunohistochemistry in biopsy samples of 93 glomerulonephritis patients and healthy controls, and the regulation of NGALR by the proinflammatory cytokines, TGF-β1, TNF-α and IL-1β in HMc was analyzed by real-time PcR and Western blotting. NGALR was found to be expressed in glomeruli. Its expression was significantly higher in acute proliferative glomerulonephritis and lupus nephritis than that in other types of glomerulonephritis or healthy kidney tissues. In in vitro experiments, both mRNA and protein levels of NGALR were dramatically induced by treatment of IL-1β, whereas TGF-β1 or TNF-α did not have the same effect. Furthermore, it was shown that the IL-1β-induced NGALR expression is mediated via the MAPK/ERK signaling pathway by using pharmacological inhibitors. Interestingly, the basal mRNA levels of NGAL detected in HMc, could be induced by IL-1β. However, NGAL protein could not be detected, even with IL-1β treatment. The ability of HMc to express NGAL protein was ascertained by exogenous administration of NGAL. In conclusion, the data show that NGALR is differentially expressed in human glomerular disease and is significantly up-regulated by Il-1β in HMc via MAPK/ERK activation. Furthermore, exogenous NGAL can be uptaken into HMc.
Introduction
Neutrophil gelatinase-associated lipocalin (NGAL) is a 25-kda protein which belongs to the lipocalin superfamily. NGAL was initially detected in activated neutrophils (1), in accordance with its role as an innate antibacterial factor (2). NGAL receptor (NGALR) is one of the cellular receptors of NGAL identified recently (3), which was first isolated from murine FL5.12 cells (4). This specific receptor probably has a fundamental role in NGAL endocytosis and cellular trafficking (4, 5) .
NGAL protein accumulation in the blood and urine can be detected only within a few hours of acute kidney injury (AKI) (6-9). These characteristics of NGAL have made it a promising biomarker of AKI, abundant in the blood and urine (5, (10) (11) (12) (13) (14) . Furthermore, recent evidence also suggests that NGAL may be involved in the pathophysiological process of chronic kidney diseases (cKd), such as polycystic kidney disease and chronic glomerulonephritis (15). Patients with systemic lupus erythematosus, IgA nephropathy, membranous (MGN) or membranoproliferative glomerulonephritis (MPGN) have higher urinary and serum NGAL levels compared to normal controls (16) (17) (18) (19) . However, the function of NGAL besides being a biomarker, remains unclear. Further research is needed to ascertain the role of this protein in the pathophysiological processes of some cKd-associated conditions.
Several studies have investigated the relationship between NGALR and diseases. cui et al (20) have shown that NGALR hypomethylation contributes to its expression in esophageal carcinomas and that this overexpression may play a role in the pathogenesis of this disease. Vinuesa et al (21) have presented evidence indicating that the regenerative function of Lcn2 (the murine homolog of NGAL) is influenced by the inflammatory status of the kidney and the expression of Lcn2 receptors. The expression of NGALR in the kidney, especially in the injured glomeruli is unclear, and furthermore, no studies have demonstrated the effects of pro-inflammatory cytokines on NGALR expression.
Although it is believed that there is nearly no expression of NGAL in glomeruli (22), where intrinsic cells, such as the mesangial cells, play important roles in the occurrence and development of renal fibrosis (23), it is possible that some intrinsic cells in glomeruli could express NGALR, the specific receptor of NGAL. It is thus possible, that NGAL could have some function in chronic glomerulonephritis via being recruited by NGALR and engulfed by intrinsic cells.
Therefore, the present study focused on the expression of NGALR in several types of glomerulonephritis by using immunohistochemistry. We also evaluated the expression of NGALR in mesangial cells under inflammatory conditions and the corresponding alterations in NGAL levels. Our research should provide useful data for investigation of the possible roles of NGAL-NGALR in the progression of cKd.
Materials and methods
Patients. In order to examine the expression of NGALR in the human injured glomeruli, renal biopsy samples were used for immunohistochemical staining. Ninety-three cases of kidney needle biopsies, including 6 cases of healthy kidney tissue (distant from the kidney tumour), 14 cases of MPGN, 10 cases of minimal change disease (Mcd), 9 cases of focal segmental glomerulosclerosis (FSGS), 18 cases of IgA nephropathy, 11 cases of MGN, 6 cases of acute proliferative glomerulonephritis (APGN) and 19 cases of lupus nephritis (LN), were obtained from the department of Pathology, Shanghai Medical college, Fudan University, in accordance with local ethics guidelines. All the patients were diagnosed by light microscopy, electron microscopy and immunofluorescence.
Immunohistochemistry. Briefly, deparaffinized 2 µm sections were stained with rabbit anti-NGALR antibody (ProSci Inc., USA). The concentration of the antibody was 1.5 µg/ml. Immobilized antibodies were detected by the avidin-biotinperoxidase technique (Vector Laboratories, UK). dAb was used as the chromogen and hematoxylin as the nuclear counterstaining agent. The primary antibody was omitted in the negative control. The positive case rate of staining was defined as the proportion of cases with positive staining among the total number of cases in each group (24).
Cell culture. HMc were purchased from (Sciencell Research Laboratories, USA). HMc were incubated in RPMI-1640 with 10% newborn serum at 37˚C in 95% air and 5% CO 2 at a concentration of 2x10 5 cells/2 ml in a 6-well tissue culture plate. After 24 h the HMc were treated with 10 ng/ml TGF-β1 (R&d Systems, USA), 10 ng/ml TNF-α (Sigma, USA) or 10 ng/ml IL-1β (Sigma, USA), respectively for 12, 24 and 48 h or with 10 µM UO126 (Cell Signaling Technologies, USA). The concentrations of these cytokines were selected according to previous published studies (25, 26) .
Total RNA isolation and RT-PCR. Total RNA was extracted from cells with TRIzol (Invitrogen, USA). First-strand cdNA was reverse transcribed from 2 µg total RNA in a total volume of 20 µl using the Reverse Transcription System (Takara, Japan) according to the manufacturer's instructions.
Semiquantitative PcR was performed using Taq dNA polymerase (Takara) in a bio-Rad S1000 Thermal cycler. After initial denaturation (5 min at 94˚C), cDNA was subjected to 30 cycles of PcR. The primer set for the human NGAL was forward 5'-TcAccTccGTccTGTTTAGG-3' and reverse 5'-cGAAGTcAGcTccTTGGTTc-3' (27). The expression of β-actin was used for normalization. The β-actin primer set was forward 5'-TTcTAcAATGAGcTGcGTGTGG-3' and reverse 5'-GTGTTGAAGGTcTcAAAcATGAT-3'. The PcR annealing temperature was 60˚C for human NGAL and 59˚C for β-actin. PcR products were separated on a 2% agarose gel.
Real-time PCR. The oligonucleotide primers designed for NGALR1, NGALR2, and β-actin were as follows: NGALR1, 5'-TGGGATTGTGAGcATccTATcTT-3' and 5'-GGcAGc cTcGTTcAGATcTc-3'; NGALR2, 5'-GGcAAAATcGAc AAcAcTGTAGAG-3' and 5'-cGTGGGcAccGcATcT-3'; β-actin, 5'-cAAcTGGGAcGAcATGGAGAAA-3' and 5'-GA TAGcAAcGTAcATGGcTGGG-3' (20). Each primer spanned a different exon to avoid amplification of contaminating genomic dNA.
Real-time quantitative PcR was performed using the Rotor-Gene 3000 (Corbett Research, Australia). Briefly, each PcR mixture contained cdNA, Premix ExTaq (Takara) and a primer pair in a final volume of 20 µl. After activation of Taq polymerase at 95˚C for 10 sec, PCR was performed for 40-50 cycles, with each cycle consisting of a denaturion step at 95˚C for 5 sec, annealing, and extending at 60˚C for 30 sec. These served as the standard curves from which we determined the rate of change in the threshold cycle values. The amount of target gene expression was calculated from the standard curve, and quantitative normalization of NGALR1 and NGALR2 cdNA in each sample was performed using β-actin as an internal control.
Western blot analysis. cells were lysed quickly using 1x SdS buffer on ice, boiled for 5 min and then stored at -80˚C until use. Samples were subjected to 10% SdS-PAGE, transferred to polyvinylidene difluoride membranes (Millipore, Eschborn, Germany). The membranes were probed with antibodies against NGALR (ProSci Inc.), NGAL (Abcam, USA), phosphop44/42MAPK (cell Signaling Technologies), p44/42MAPK (cell Signaling Technologies) and β-actin (Sigma) as a loading control for 1 h at 37˚C, then incubated overnight at 4˚C. Following incubation with HRP-conjugated secondary antibodies (cell Signaling Technologies), the immunoreaction was visualized by enhanced chemiluminescence and film exposure. Each experiment was repeated at least three times.
Statistical analysis. Statistics were calculated using SPSS software. Statistical comparisons between groups were made using the Fisher's exact test and the analysis of variance (ANOVA) with pairwise multiple comparisons made using the Fisher's protected least significant difference test. A p-value of <0.05 was defined as statistically significant.
Results

Expression of NGALR in the glomeruli from different types of glomerulonephritis.
Using immunohistochemistry, the positive signal of NGALR expression was observed in glomeruli of APGN and LN, while in IgA nephropathy, Mcd, MPGN, MGN, FSGS and healthy kidney tissue, the signals were almost negative. The positive staining was mainly distributed within the mesangium with low expression in the peripheral area of the capillary tufts. Positive staining was also observed in some parietal epithelia of the bowman's capsule, crescents and a portion of proximal tubular epithelial cells in all the cases (Fig. 1) . In addition, the degree of NGALR expression in the glomeruli was somewhat different among the various types of glomerulonephritis. The proportion of positive cases was 100% in APGN, 89% in LN, while it was only about 10% in other types of glomerulonephritis, nearly similar to that in healthy kidney tissue (Table I ). The statistical analysis demonstrated that the positive case rate was significantly higher in LN and APGN than in IgA nephropathy, MGN, Mcd, FSGS, MPGN and healthy kidney tissues (p<0.01). There were no statistically significant differences between FSGS, Mcd, minor abnormality and healthy kidney tissue (p>0.05). . In order to screen for possible inducers of NGALR expression in some types of nephrites, normal HMc were treated by the common pro-inflammatory cytokines, TGF-β1 (10 ng/ml), TNF-α (10 ng/ml) and IL-1β (10 ng/ml) for 12, 24 and 48 h. Western blot analysis and real-time PcR revealed that the basal protein levels of NGALR were low in normal HMcs ( Fig. 2A) and somewhat increased in the groups exposed to the cytokines, TGF-β1 and TNF-α, with no significant differences compared to the normal control ( Fig. 2c and d) .
Elevated expression of NGALR in HMC mediated by
The protein levels of NGALR, were up-regulated from their basal levels by IL-1β treatment as determined by Western blot analysis. The increased exprssion was time-but not dose-dependent, and the maximal induction was observed 48 h after treatment and was 4-fold higher ( Fig. 2b and E) .
As determined by real-time PcR, the mRNA expression of the alternatively spliced NGALR variants, NGALR1 and NGALR2 (20), were significantly increased in the groups exposed to IL-1β treatment compared to the normal controls, and this increased expression was time-dependent (Fig. 3) .
The IL-1β-induced increase in the expression of NGALR is mediated through activation of the MAPK/ERK signaling pathway. We further investigated which molecules are implicated in IL-1β signaling, which in turn may mediate the positive effect of IL-1β on NGALR expression. The ability of IL-1β to activate MAPK has been examined in mesangial cells (28) . We demonstrated that the increased NGALR expression induced by IL-1β requires the activation of the MAPK/ERK pathway. IL-1β stimulation resulted in a rapid, transient phosphorylation of ERK (Fig. 4A) . ERK activation was maximal at 3 h (at which point it was about 4-fold higher) and returned to basal levels after 6 h. Next, in order to investigate whether ERK activation is a key point in the induction of NGALR expression by IL-1β, we examined the effects of a MAPK/ERK inhibitor on the IL-1β-induction of NGALR. HMc were treated for 1 h with the ERK inhibitor, U0126 (10 µM) followed by stimulation with 10 ng/ml IL-1β for 16 h. The increased expression of NGALR was partly inhibited following treatment with U0126 (Fig. 4b) . In addition, when HMc were treated for 1 h with the U0126 following stimulation with 10ng/ml IL-1β for 3 h, the ERK inhibitor U0126 strongly suppressed the phosphorylation of ERK, which indicated that it specifically inhibits ERK activity (Fig. 4c) . These results suggest that ERK is one of the signaling pathways contributing to the IL-1β-mediated NGALR induction in HMc.
Changes of NGAL expression in HMC. First, we confirmed by PcR and Western blot analysis that NGAL mRNA was expressed in HMc, even though no NGAL protein could be detected. Furthermore, NGAL mRNA was induced by IL-1β ( Fig. 5A and b) . To further investigate whether HMcs could engulf NGAL that was bound to NGALR, we analyzed the Whole cell lysates from HMc stimulated for the indicated number of hours with 10 ng/ml IL-1β were separated by SdS-PAGE and immunoblotted with an antibody to phosphorylated ERK, JNK, p38 followed by immunoblotting with an antibody to total ERK, JNK, p38 to determine equality of loading. (B) Cells were preincubated for 1 h in RPMI-1640 with or without 10 µM U0126 (U) followed by Western blotting with or without 10 ng/ml IL-1β (I) for 16 h. Total cell lysates were then subjected to Western blot analysis with antibodies against NGALR and β-actin. (c) cells were preincubated for 1 h with or without 10 µM U0126 following stimulation with 100 ng/ml IL-1β for 3 h, and then total cell lysates were subjected to Western blot analysis with antibodies to phospho-ERK and ERK. The results show that IL-1β-induced NGALR expression was partly ERK-dependent. The fold-induction relative to the control was determined. data are the mean ± Sd of values from three independent experiments. NGAL protein level in HMc culture medium at different time-points after adding exogenous NGAL. The results demonstrate a time-dependent decrease of NGAL protein levels in cultured HMc, which indicates the uptake of NGAL by HMc (Fig. 5c ). This phenomenon is in accordance with the in vivo protein degradation process.
Discussion
NGAL is a 25-kDa glycoprotein, first found to be an acute phase reactant secreted by the liver and then identified as a matrix protein of specific granules of human neutrophils (29). During inflammation or exposure to serum, LPS, and cytokines such as the human fibroblast growth factor and IL-1β (30-33), NGAL has been found to be strongly induced in several organs and in a variety of cultured cells, such as the renal tubular epithelial cells.
Since it can be induced within a few hours in the blood and urine during AKI, NGAL levels may predict the acute worsening of unstable nephropathies and even the future appearance of AKI after treatments. Furthermore, recent evidence suggests that NGAL may be involved in the pathophysiological process of cKd, such as polycystic kidney disease and glomerulonephritis (15). In these renal diseases, NGAL levels in the blood and urine are altered.
It is generally acknowledged that in addition to NGAL being the most promising next-generation biomarker in clinical nephrology, it promotes renal tubular epithelial cell growth and differentiation in response to ischemic injuries (32). currently, despite some reasearch in progress, the biological significance of NGAL in cKd, especially in glomerulonephritis needs further examination.
Recently, the cellular surface receptor, NGALR, has been identified as one of the NGAL specific receptors (3), which probably has a fundamental role in NGAL endocytosis and cellular trafficking. A series of studies has suggested that NGAL is internalized inside the cell as a protein alone (Apo-NGAL) or in a complex with iron-binding siderophores (Holo-NGAL) after interaction with NGALR, which mediates a new iron delivery pathway that functions distinctly from the transferrin pathway (5,34). However, the expression of NGALR or the effect of pro-inflammatory cytokines on NGALR expression in the kidneys is not well known especially in renal glomeruli of various types of glomerulonephritis.
It is generally known that HMc play a crucial role in glomeruli under both normal physiological and pathological conditions. They provide structural support and regulate the glomerular filtration rate (35). In addition, the mesangium serves as a source and target of various kinds of cytokines, thus contributing to the pathophysiology of various types of glomerular diseases (36). Aberrant proliferation of mesangial cells and extracellular matrix deposition is a common finding in several types of glomerulonephritis induced by a variety of initial insults, whether metabolic (as in diabetic nephropathy) or immunological (as in IgA nephropathy and LN) (23).
Therefore, it is important to detect the expression of NGALR in mesangial cells in order to study the biological significance of NGAL in chronic renal diseases. The hypothesis is that NGAL could play a role in cKd, via interaction with the NGALR which was found in intrinsic cells within glomeruli.
We postulate that NGALR is an important factor involved in the pathological response to decreased NGAL expression in an in vivo microenvironment.
The present study shows that the expression of NGALR protein was significantly higher in renal glomeruli of APGN and LN compared to normal kidney tissue and other types of glomerulonephritis, and that the positive staining was mainly distributed at the mesangium. However, whether NGALR is expressed and secreted by HMc or some other cell types remains uncertain. We therefore, performed further in vivo experiments. The results illustrate that NGALR protein is expressed in HMc.
Further examination is needed to define the reasons why NGALR protein levels were higher in APGN and LN than in the other types of glomerulonephritis. It is worth noting that inflammation is a common feature in glomerulonephritis and worsens during the progression toward end-stage renal disease (ESRD). We must point out the existence of severe inflammatory cells and the occurence of neutrophilic granulocyte infiltration in APGN and LN (especially in class Ⅳ). In order to investigate the possible reasons, we chose to use common pro-inflammatory cytokines to stimulate HMC. These data were confirmed in in vitro cell experiments by RT-PcR and Western blot analyses. We found that NGALR mRNA and protein levels were up-regulated in HMc stimulated by IL-1β, but not by TGF-β1 or TNF-α, and that this up-regulation was time-and dose-independent. Furthermore, our results demonstrated that IL-1β-induced NGALR expression was mediated via the MAPK/ERK signaling pathway. The data indicate that the up-regulation of NGALR might be associated with IL-1β-induced inflammatory gene expression in HMC.
Immunohistochemistry results demonstrated that NGAL was highly expressed in proximal tubular epithelial cells in the normal and injured kidney, with low expression in other areas of the kidney, such as the mesangium (22). We also found that NGAL protein was absent from normal or stimulated HMc, whereas NGAL mRNA was up-regulated in HMc treated with IL-1β and this increasing expression was time-dependent. This illustrates that the process of protein translation is blocked in vivo. However, the protein expression of NGAL in HMcs was detected upon exogenous treatment with NGAL. Whether NGAL in the in vivo microenvironment could be delivered into mesangial cells by NGALR, needs further experimentation. However, our research provides fundamental data for the possible roles of NGAL-NGALR in the progression of cKd. Future studies are needed to further address this issue.
